$0.870700
0.011.24%
At Close: -
$0.889700
0.022.18%
After Hours: 7:53 PM EDT
15 minutes delayed
Seres Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Seres Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.22 | $-0.27 | 18.5 % |
Mar 2024 | 2024-05-08 | $-0.27 | $-0.34 | 20.6 % |
Dec 2023 | 2024-03-05 | $-0.32 | $-0.50 | 36.0 % |
Sep 2023 | 2023-11-02 | $-0.37 | $-0.50 | 26.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $0 | $250.00K | -100.0 % |
Sep 2023 | 2023-11-02 | $310.00K | $1.87M | -83.4 % |
Jun 2023 | 2023-08-08 | $126.47M | $125.50M | 0.78 % |
Mar 2023 | 2023-05-09 | $-522.00K | $1.38M | -137.8 % |
Seres Therapeutics (MCRB) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.22, which beat the estimate of $-0.27.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.